Vol. 35 (1987) effects on the impaired cell-mediated immunological functions. We also reported that two fragments8) of thymosin ƒÀ4, H-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-OH (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) and H-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-OH (31 39), and a fragment9) of thymosin fl9, H-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-OH (16 25) anisole prior to the next coupling reaction. First, the C-terminal fragment, Boc-(35-38)-OBzl, was prepared stepwise starting from Boc-Lys(Z)-OBzl by the HOBT-WSCI procedure16) except for the introduction of a Gln residue, which was introduced by the NP active ester procedure.17) Next, the two fragments containing Glu(OcHex), Boc-(30-34)-NHNH-Troc and Boc-(21-24)-NHNH-Troc, were prepared stepwise by the HOBT-WSCI procedure16) except for the introduction of a Gln residue, which was introduced by the NP active ester procedure.17) The two fragments thus obtained were treated with Zn15) in AcOH to remove Troc groups, and the zinc acetate was removed by treatment with EDTA to give the required hydrazides in analytical pure form. The hydrazine test on the thin-layer chromatograms and elemental analysis data were consistent with homogeneity of the desired products. Thus these fragments were prepared without exposing the corresponding ester to hydrazide. Then, Boc-(25-29)-OTce, was prepared stepwise starting from Boc-Pro-OTce by the HOBT-WSCI procedure16) except for the introduction of an Asn residue, which was introduced by the NP active ester procedure.17) During the courses of NP steps, HOBT was used as a coupling reaction accelerator.16) The resulting pentapeptide ester was treated with Zn18) in AcOH-H20 (4 : 1) to remove the Tce, and the zinc acetate was removed by treatment with EDTA to give Boc-(25-29)-OH in analytically pure form. The five fragments thus obtained were then assembled successively by the azide procedure18) and the HOSu-WSCI procedure19) according to the routes illustrated in Fig. 2 . The amount of the acyl component in each fragment condensation was increased from 1.6 to 3 eq as the chain elongation proceeded. The solubility of protected intermediates in DMF decreased remarkably with chain elongation. Consequently, mixtures of DMF-DMSO had to be employed for the subsequent condensation reactions.
The first fragment condensation product, Boc-(30-38)-OBzl, was purified by gelfiltration on Sephadex LH-20 using DMF containing 3% H2O as the eluent and the other three intermediates were purified by repeated precipitation from DMF or DMSO with Me0H. Throughout this synthesis, Ile was taken as a diagnostic amino acid. Each intermediate was subjected to acid hydrolysis and the recovery of Ile was compared with those of newly added amino acids in order to ascertain satisfactory incorporation, after each condensation. The homogeneity of every intermediate was further ascertained by elemental analysis and TLC. Moreover, we attempted to take advantage of the well-known fact that Dallo-Ile or D-allo-Thr is easily separable from the parent amino acid, Ile or Thr, by using an amino acid analyzer to detect the degree of racemization during the coupling reactions.20) For this purpose, we chose the two synthetic fragments, Boc-(30-34)-NHNH2
and Boc-(16-20)-NHNH2, bearing Ile and Thr in the C-terminus, respectively. Fortunately, after coupling of these fragments, we could not detect any D-allo-Ile or D-allo-Thr in the resulting peptides.
In the final step of the synthesis, the protected tricosapeptide benzyl ester was treated with 1 M TFMSA-thioanisole in TFA in the presence of (Me)2Se in an ice-bath for 100 min to remove all the protecting groups employed. (Me)2Se was used as an accelerator for the cleavage of protecting groups. 21 The deprotected peptide was next precipitated with dry ether, converted to the corresponding acetate with Amberlite IR-400 (acetate form) and then treated with 1 N NI-140H to reverse a possible N-40 shift at the Ser and Thr residues.22) The crude peptide was purified by gel-filtration on Sephadex G-25 and then ion-exchange column chromatography on a CM-Sephadex C-25 column with a linear gradient of pH 6.51 ammonium acetate buffer (0-4.07 M), followed by preparative TLC. The tricosapeptide thus obtained was homogeneous on TLC in two different solvent systems and paper electrophoresis (pH 3.1 acetate buffer). The peptide also exhibited a single peak on HPLC (Fig.  4) . Its purity was further confirmed by amino acid analysis after acid hydrolysis and PHA-P-activated lymphocytes, I = fluorescence intensity of PHA-P-nonactivated lymphocytes and 4= fluorescence intensity of ethydium bromide. c) Normal peripheral lymphocytes. d) Patient's peripheral lymphocytes. e) Incubation was carried out for 12 h at 37°C. f) This peptide8) had no effect on the impaired blastogenic response of PHA-stimulated T-lymphocytes at the concentration of 4.1 x g) p<0.05, when compared to normal persons by using Student's t-test. h) p<0.01, when compared to the uremic patient by using Student's t-test. 
(1 g) was treated with TFA-anisole (10 m1-2 ml) as described above. 
